Targeted drug treatments focus on certain defects within tumor cells. By blocking these defects, targeted drug treatments can cause tumor cells to die. Many targeted therapies are still being studied and implemented in clinical trials, such as the Ivy Brain Tumor Center's Phase 0/2 clinical trials.